Cure My Disease

Don't miss your cure!

 Log in / Sign up

Catheter timing could cut infections and speed recovery after colorectal surgery

NCT ID NCT06769087

Symptom relief Sponsor: Seoul St. Mary's Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only This study
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 09, 2026 · Last updated Jul 10, 2026 · Updated 1 time

Summary

This trial tests whether removing the urinary catheter immediately after colorectal cancer surgery (before anesthesia wears off) is as safe and effective as removing it the next day. The goal is to lower the risk of urinary tract infections and help patients recover faster. About 316 adults undergoing colorectal cancer surgery will be randomly assigned to one of the two timing groups, and researchers will track urinary retention, infection rates, and the need for catheter reinsertion.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
urinary catheter removal timing (immediate vs. postoperative day 1)
What this could lead to
If removing the catheter immediately after surgery proves safe and effective, it could become a standard practice to reduce urinary tract infections and help patients recover faster after colorectal cancer surgery.
What could go wrong
This is a single-center trial with 316 participants, so results may not apply to all hospitals or patients. Removing the catheter too early may increase the risk of urinary retention requiring reinsertion.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 316 people

The number the study aims to enrol. It can still change while the study runs.

Started

Dec 2024

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

19 to 80 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * 19 years old 80 years old * Patients diagnosed with colorectal cancer who are eligible for radical resection surgery * Patients who underwent open, laparoscopic, or robotic surgery * Written informed consent Exclusion Criteria: * Patients who have undergone two or more major abdominal surgeries, including lateral pelvic lymph node dissection, at the same time * Patients who require continuous monitoring through a urinary catheter due to hemodynamic instability or massive bleeding, etc. * Patients who have undergone conventional treatment in cases other than distant metastasis or R0 resection * Patients who have developed complications related to the urinary system during surgery and require maintenance of a urinary catheter such as a urethral stent * Patients who have undergone urinary surgery such as urethral stent placement, cystectomy, or urostomy in the past * Patients who are on hemodialysis or peritoneal dialysis due to chronic renal failure * Patients who cannot participate in a clinical trial at the discretion of a physician * Patients who do not wish to participate in the study

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Colorectal cancer are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

colorectal cancer colorectal neoplasm Postoperative Complications

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Colorectal cancer Enhanced recovery after surgery Postoperative complication Urinary retention postoperative

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    The full official record for this study. This one lists no contact details, but it is the first place any would appear.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Seoul St.Mary's hospital, the Catholic university of Korea

    Seoul, Seoul, 06591, South Korea

More trials for these conditions

Other studies related to the condition(s) this trial covers.